Results 41 to 50 of about 497 (74)

[Prognosis of in hospital nonagenarians with acute kidney injury]. [PDF]

open access: yesAn Sist Sanit Navar, 2021
Quiroga B   +9 more
europepmc   +1 more source

[Screening for Chronic Kidney Disease in the Community Pharmacy. CRIERFAC Study: Description of the Methodology]. [PDF]

open access: yesFarm Comunitarios
Salar Ibáñez L   +4 more
europepmc   +1 more source

Mapping Lysosomal Storage Disorders with Neurological Features by Cellular Pathways: Towards Precision Medicine. [PDF]

open access: yesCurr Issues Mol Biol
Makridou A   +6 more
europepmc   +1 more source

Scientific Opinion on Flavouring Group Evaluation 69, Revision 1 (FGE.69Rev1): consideration of aromatic substituted secondary alcohols, ketones and related esters evaluated by JECFA (57th meeting), structurally related to aromatic ketones from chemical group 21 evaluated by EFSA in FGE.16Rev2. [PDF]

open access: yesEFSA J, 2020
EFSA Panel on Food Additives and Flavourings (FAF)   +25 more
europepmc   +1 more source

[Revisit after discharge from the emergency department in a cohort of patients with COVID-19 pneumonia and analysis based on the healthcare resource used for follow-up. RESALSEVID study]. [PDF]

open access: yesJ Healthc Qual Res, 2023
Albert A   +17 more
europepmc   +1 more source

[Biomarkers of oxidative stress and inflammation in contrast-associated acute kidney injury]. [PDF]

open access: yesAn Sist Sanit Navar
Stoll E   +3 more
europepmc   +1 more source

Scientific Opinion on Flavouring Group Evaluation 67, Revision 3 (FGE.67Rev3): consideration of 23 furan-substituted compounds evaluated by JECFA at the 55th, 65th, 69th and 86th meetings. [PDF]

open access: yesEFSA J, 2021
EFSA Panel on Food Additives and Flavourings (FAF)   +27 more
europepmc   +1 more source

Home - About - Disclaimer - Privacy